103 related articles for article (PubMed ID: 16957915)
21. Comparison of two high-performance liquid chromatographic methods for monitoring plasma concentrations of haloperidol and reduced haloperidol.
Pan L; Rosseel MT; Belpaire FM
Ther Drug Monit; 1998 Apr; 20(2):224-30. PubMed ID: 9558139
[TBL] [Abstract][Full Text] [Related]
22. The measurement of haloperidol and reduced haloperidol in neonatal hair as an index of placental transfer of maternal haloperidol.
Uematsu T; Yamada K; Matsuno H; Nakashima M
Ther Drug Monit; 1991 Mar; 13(2):183-7. PubMed ID: 2053128
[TBL] [Abstract][Full Text] [Related]
23. Determination of haloperidol and hydroxy haloperidol in human plasma by high performance liquid chromatography.
Pommery J; Foulon O; Morineau G; Lhermitte M; Levron JC; Erb F
Ann Biol Clin (Paris); 1990; 48(7):455-8. PubMed ID: 2278409
[TBL] [Abstract][Full Text] [Related]
24. Possible interference by the reduced haloperidol metabolite with the radioimmunoassay and radioreceptor assay of blood haloperidol.
Korpi ER; Ko GN; Phelps BH; Wyatt RJ
J Clin Psychopharmacol; 1984 Dec; 4(6):332-5. PubMed ID: 6512001
[TBL] [Abstract][Full Text] [Related]
25. Chirality of reduced haloperidol in humans.
Eyles DW; McGrath JJ; Stedman TJ; Pond SM
Eur Neuropsychopharmacol; 1998 May; 8(2):127-9. PubMed ID: 9619691
[TBL] [Abstract][Full Text] [Related]
26. Correlation of haloperidol levels between saliva and plasma of acutely ill schizophrenic patients.
Jain T; Bhandari A; Ram V; Sharma S; Parakh M; Parakh MC
Clin Biochem; 2011 Jun; 44(8-9):675-80. PubMed ID: 21458435
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of itopride in human serum by high-performance liquid chromatography with fluorescence detection and its application to a bioequivalence study.
Singh SS; Jain M; Sharma K; Shah B; Vyas M; Thakkar P; Shah R; Singh S; Lohray B
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):213-20. PubMed ID: 15734161
[TBL] [Abstract][Full Text] [Related]
28. Resolution of the interference from carbamazepine and diphenhydramine during reversed-phase liquid chromatographic determination of haloperidol and reduced haloperidol.
Vatassery GT; Holden LA; Dysken MW
J Anal Toxicol; 1993 Sep; 17(5):304-6. PubMed ID: 8107466
[TBL] [Abstract][Full Text] [Related]
29. Determination of bisphenol A in rat brain by microdialysis and column switching high-performance liquid chromatography with fluorescence detection.
Sun Y; Nakashima MN; Takahashi M; Kuroda N; Nakashima K
Biomed Chromatogr; 2002 Aug; 16(5):319-26. PubMed ID: 12210505
[TBL] [Abstract][Full Text] [Related]
30. High performance liquid chromatographic determination of azithromycin in serum using fluorescence detection and its application in human pharmacokinetic studies.
Bahrami G; Mirzaeei S; Kiani A
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(2):277-81. PubMed ID: 15876560
[TBL] [Abstract][Full Text] [Related]
31. Quantitative determination of clozapine in serum by instrumental planar chromatography.
Mennickent S; Sobarzo A; Vega M; Godoy CG; de Diego M
J Sep Sci; 2007 Aug; 30(13):2167-72. PubMed ID: 17638358
[TBL] [Abstract][Full Text] [Related]
32. Sensitive determination of 1- and 2-naphthol in human plasma by HPLC-fluorescence detection with 4-(4,5-diphenyl-1H-imidazol-2-yl)benzoyl chloride as a labeling reagent.
Ohyama K; Kishikawa N; Matayoshi K; Adutwum LA; Wada M; Nakashima K; Kuroda N
J Sep Sci; 2009 Jul; 32(13):2218-22. PubMed ID: 19569101
[TBL] [Abstract][Full Text] [Related]
33. Haloperidol and reduced haloperidol serum levels: correlation with psychopathology in acute schizophrenia.
Stevens A; Mahal A; Gaertner HJ
Pharmacopsychiatry; 1992 Sep; 25(5):218-23. PubMed ID: 1409866
[TBL] [Abstract][Full Text] [Related]
34. Liquid chromatographic determination of reduced haloperidol and haloperidol concentrations in packed red blood cells from humans.
Vatassery GT; Herzan LA; Dysken MW
J Anal Toxicol; 1990; 14(1):25-8. PubMed ID: 2314059
[TBL] [Abstract][Full Text] [Related]
35. 1,3,5,7-Tetramethyl-8-aminozide-difluoroboradiaza-s-indacene as a new fluorescent labeling reagent for the determination of aliphatic aldehydes in serum with high performance liquid chromatography.
Xiong XJ; Wang H; Rao WB; Guo XF; Zhang HS
J Chromatogr A; 2010 Jan; 1217(1):49-56. PubMed ID: 19942225
[TBL] [Abstract][Full Text] [Related]
36. Sensitive electrochemical high-performance liquid chromatography assay for the simultaneous determination of haloperidol and reduced haloperidol.
Eddington ND; Young D
J Pharm Sci; 1988 Jun; 77(6):541-3. PubMed ID: 3171937
[TBL] [Abstract][Full Text] [Related]
37. High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations.
Fang J; Gorrod JW
J Chromatogr; 1993 May; 614(2):267-73. PubMed ID: 8314939
[TBL] [Abstract][Full Text] [Related]
38. Highly sensitive determination of nitric oxide in biologic samples by a near-infrared BODIPY-based fluorescent probe coupled with high-performance liquid chromatography.
Zhang HX; Chen JB; Guo XF; Wang H; Zhang HS
Talanta; 2013 Nov; 116():335-42. PubMed ID: 24148412
[TBL] [Abstract][Full Text] [Related]
39. Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection.
del Rosario Brunetto M; Contreras Y; Clavijo S; Torres D; Delgado Y; Ovalles F; Ayala C; Gallignani M; Estela JM; Martin VC
J Pharm Biomed Anal; 2009 Sep; 50(2):194-9. PubMed ID: 19446420
[TBL] [Abstract][Full Text] [Related]
40. Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection.
Lin F; Chandrasekaran G; de Gooijer MC; Beijnen JH; van Tellingen O
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():9-17. PubMed ID: 22727754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
